Omri Drory, Ph.D.
General Partner ·
Tel Aviv/Menlo Park
Post ImagePost ImagePost Image
2-time scientist-founder. Founder at Genome Compiler, founding CEO of Head of NFX Bio.
NFX Logo
NFX Logo
NFX Logo
NFX Logo
Focus Areas
Omri's Story

Omri Amirav-Drory, Ph.D. is the General Partner at NFX Bio. He is a scientist and an operator who has founded, scaled, and invested in some of today’s most important techbio companies.

Before becoming an investor, Omri was the Founding CEO of Genome Compiler, which developed software for genetic engineers and molecular and synthetic biologists. He led the company to a successful acquisition by Twist Bioscience, a next-generation DNA synthesis company currently valued at ~$2.5 Billion. Omri stayed at Twist for almost three years after the acquisition as the Head of Corporate Development.

After leaving Twist, Omri became the Founding Partner at Tech.Bio where he invested and advised in companies like Mammoth Biosciences, immunai, C2i Genomics, and more. Now as an investor, Omri understands what it means to be a Scientist-CEO and is committed to a future where this is the norm, not the exception.

Notable Investments
Mammoth Biosciences
C2i Genomics
Talus Bio
Twist BioscienceIPO
Operating Experience
General Partner
NFX Capital · 2020 - Present
Founding Partner · 2018 - Present
Head of Corporate Development
Twist Bioscience · 2016 - 2018
Founder & CEO
Genome Compiler (acquired) · 2011 - 2016
Postdoctoral Associate
Stanford University School of Medicine · 2007 - 2011
Education & Affiliations

Postdoctoral , Biochemistry and Molecular Biology, Stanford University

Ph.D., Biochemistry, Tel Aviv University

BS, Biochemistry and Molecular Biology, Tel Aviv University


Proud husband and father of three, two boys and one girl; avid reader of science fiction.

Try ChatNFX